Does DATOPOTAMAB DERUXTECAN-DLNK Cause Off label use? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Off label use have been filed in association with DATOPOTAMAB DERUXTECAN-DLNK. This represents 18.8% of all adverse event reports for DATOPOTAMAB DERUXTECAN-DLNK.
31
Reports of Off label use with DATOPOTAMAB DERUXTECAN-DLNK
18.8%
of all DATOPOTAMAB DERUXTECAN-DLNK reports
8
Deaths
6
Hospitalizations
How Dangerous Is Off label use From DATOPOTAMAB DERUXTECAN-DLNK?
Of the 31 reports, 8 (25.8%) resulted in death, 6 (19.4%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DATOPOTAMAB DERUXTECAN-DLNK. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does DATOPOTAMAB DERUXTECAN-DLNK Cause?
Disease progression (49)
Stomatitis (27)
No adverse event (22)
Nausea (11)
Prescribed underdose (9)
Death (7)
Interstitial lung disease (7)
Dyspnoea (6)
Mucosal inflammation (5)
Product prescribing issue (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DATOPOTAMAB DERUXTECAN-DLNK Alternatives Have Lower Off label use Risk?
DATOPOTAMAB DERUXTECAN-DLNK vs DAUNORUBICIN
DATOPOTAMAB DERUXTECAN-DLNK vs DAXIBOTULINUMTOXIN A-LANM
DATOPOTAMAB DERUXTECAN-DLNK vs DAYTRANA
DATOPOTAMAB DERUXTECAN-DLNK vs DECITABINE
DATOPOTAMAB DERUXTECAN-DLNK vs DEFERASIROX